Business of the House

Andrew Rosindell Excerpts

Thursday 6th February 2025 Commons Chamber

[Andrew Rosindell (Romford) (Con)]

I would like the Leader of the House to know that a number of my constituents have contacted me regarding the prescribing of antidepressant medicine in the UK and the iatrogenic harm caused to patients by antidepressant medication. Many are now diagnosed and suffering from conditions including post-acute withdrawal syndrome and post-SSRI—selective serotonin reuptake inhibitors—dysfunction. My right hon. Friend the Member for Tatton (Esther McVey) held a Westminster Hall debate on this issue only last year. However, given the severity of the concerns raised, will the Leader of the House consider a full debate in Government time on this very important matter?

[Lucy Powell]

I think every MP in the House will have had constituents contact them about the use of anti- depressants, how they are prescribed, their effects, and whether they are fully understood by those they are given to. This is a really important issue, and I will ensure that the hon. Gentleman gets a full response, but I think this would make a very good topic for a debate.